{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:54:39Z","timestamp":1790423679406,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T00:00:00Z","timestamp":1478131200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Department of Health Policy Research Programme and the Scottish Government","award":["PR-ST-0614-00008"],"award-info":[{"award-number":["PR-ST-0614-00008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s00401-016-1638-x","type":"journal-article","created":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T12:27:40Z","timestamp":1478176060000},"page":"579-595","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["UK Iatrogenic Creutzfeldt\u2013Jakob disease: investigating human prion transmission across genotypic barriers using human tissue-based and molecular approaches"],"prefix":"10.1007","volume":"133","author":[{"given":"Diane L.","family":"Ritchie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo A.","family":"Barria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander H.","family":"Peden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen M.","family":"Yull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Kirkpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Adlard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Ironside","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2034-8613","authenticated-orcid":false,"given":"Mark W.","family":"Head","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,3]]},"reference":[{"key":"1638_CR1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3201\/eid2001.130858","volume":"20","author":"MA Barria","year":"2014","unstructured":"Barria MA, Balachandran A, Morita M, Kitamoto T, Barron R, Manson J et al (2014) Molecular barriers to zoonotic prion transmission. Emerg Infect Dis 20:88\u201397","journal-title":"Emerg Infect Dis"},{"key":"1638_CR2","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/1471-2350-10-146","volume":"10","author":"MT Bishop","year":"2009","unstructured":"Bishop MT, Pennington C, Heath CA, Will RG, Knight RSG (2009) PRNP variation in UK sporadic and variant Creutzfeldt-Jakob disease highlights genetic risk factors and a novel non-synonymous polymorphism. BMC Med Genet 10:146","journal-title":"BMC Med Genet"},{"key":"1638_CR3","doi-asserted-by":"crossref","first-page":"12005","DOI":"10.1073\/pnas.1004688107","volume":"107","author":"M Bishop","year":"2010","unstructured":"Bishop M, Will RG, Manson JM (2010) Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties. Proc Natl Acad Sci USA 107:12005\u201312010","journal-title":"Proc Natl Acad Sci USA"},{"key":"1638_CR4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0140-6736(03)13867-6","volume":"362","author":"JP Brandel","year":"2003","unstructured":"Brandel JP, Preece M, Brown P, Croes E, Laplanche JL, Aquid Y et al (2003) Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK. Lancet 362:128\u2013130","journal-title":"Lancet"},{"key":"1638_CR5","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3201\/eid1806.120116","volume":"18","author":"P Brown","year":"2012","unstructured":"Brown P, Brandel JP, Sato T, Nakamura Y, MacKenzie J, Will RG et al (2012) Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg Infect Dis 18:901\u2013907","journal-title":"Emerg Infect Dis"},{"key":"1638_CR6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40478-015-0214-2","volume":"3","author":"I Cali","year":"2015","unstructured":"Cali I, Miller CJ, Parisi JE, Geschwind MD, Gambetti P, Schonberger LB (2015) Distinct pathological phenotypes of Creutzfeldt-Jakob disease in recipients of prion-contaminated growth hormone. Acta Neuropathol Commun 3:37","journal-title":"Acta Neuropathol Commun"},{"key":"1638_CR7","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1126\/science.1138718","volume":"318","author":"J Collinge","year":"2007","unstructured":"Collinge J, Clarke AR (2007) A general model for prion strains and their pathogenicity. Science 318:930\u2013936","journal-title":"Science"},{"key":"1638_CR8","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1098\/rstb.2008.0068","volume":"363","author":"J Collinge","year":"2008","unstructured":"Collinge J, Whitfield J, McKintosh E, Frosh A, Mead S, Hill AF et al (2008) A clinical study of kuru patients with long incubation periods at the end of the epidemic in Papua New Guinea. Philos Trans R Soc Lond B Biol Sci 363:3725\u20133739","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"1638_CR9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1439-0450.2006.00966.x","volume":"53","author":"M Eiden","year":"2006","unstructured":"Eiden M, Buschmann A, Kupfer L, Groschup MH (2006) Synthetic prions. J Vet Med B Infect Dis Vet Public Health 53:251\u2013256","journal-title":"J Vet Med B Infect Dis Vet Public Health"},{"key":"1638_CR10","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJM198509193131207","volume":"313","author":"CJ Gibbs Jr","year":"1985","unstructured":"Gibbs CJ Jr, Joy A, Heffner R, Franko M, Miyazaki M, Asher DM et al (1985) Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. N Engl J Med 313:734\u2013738","journal-title":"N Engl J Med"},{"key":"1638_CR11","first-page":"358","volume":"328","author":"CJ Gibbs Jr","year":"1993","unstructured":"Gibbs CJ Jr, Asher DM, Brown PW, Fradkin JE, Gajdusek DC (1993) Creutzfeldt-Jakob disease infectivity of growth hormone derived from human pituitary glands. N Engl J Med 328:358\u2013359","journal-title":"N Engl J Med"},{"key":"1638_CR12","first-page":"1016","volume-title":"Greenfield\u2019s Neuropathology","author":"MW Head","year":"2015","unstructured":"Head MW, Ironside JW, Ghetti B, Jeffrey M, Piccardo P, Will RW (2015) Prion diseases. In: Love S, Budka H, Ironside JW, Perry A (eds) Greenfield\u2019s Neuropathology, 9th edn. CRC Press, Boca Raton, pp 1016\u20131086","edition":"9"},{"key":"1638_CR13","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1136\/jnnp.2005.073395","volume":"77","author":"CA Heath","year":"2006","unstructured":"Heath CA, Barker RA, Esmonde TF, Harvey P, Roberts R, Trend P et al (2006) Dura mater-associated Creutzfeldt-Jakob disease: experience from surveillance in the UK. J Neurol Neurosurg Psychiatry 77:880\u2013882","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1638_CR14","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/9781444341256.ch39","volume-title":"Neurodegeneration: the molecular pathology of dementia and movement disorders","author":"JW Ironside","year":"2011","unstructured":"Ironside JW, Knight RSG, Head MW (2011) Iatrogenic Creutzfeldt-Jakob disease. In: Dickson DW, Weller RO (eds) Neurodegeneration: the molecular pathology of dementia and movement disorders, 2nd edn. Wiley-Blackwell, Oxford, pp 381\u2013386","edition":"2"},{"key":"1638_CR15","doi-asserted-by":"crossref","first-page":"30022","DOI":"10.1074\/jbc.M704597200","volume":"282","author":"A Kobayashi","year":"2007","unstructured":"Kobayashi A, Asano M, Mohri S, Kitamoto T (2007) Cross-sequence transmission of sporadic Creutzfeldt-Jakob disease creates a new prion strain. J Biol Chem 282:30022\u201330028","journal-title":"J Biol Chem"},{"key":"1638_CR16","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1128\/JVI.02387-09","volume":"84","author":"A Kobayashi","year":"2010","unstructured":"Kobayashi A, Sakuma N, Matsuura Y, Mohri S, Aguzzi A, Kitamoto T (2010) Experimental verification of the traceback phenomenon in prion infection. J Virol 84:3230\u20133238","journal-title":"J Virol"},{"key":"1638_CR17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/2051-5960-1-74","volume":"1","author":"A Kobayashi","year":"2013","unstructured":"Kobayashi A, Iwasaki Y, Otsuka H, Yamada M, Yoshida M, Matsuura Y et al (2013) Deciphering the pathogenesis of sporadic Creutzfeldt-Jakob disease with codon 129\u00a0M\/V and type 2 abnormal prion protein. Acta Neuropathol Commun 1:74","journal-title":"Acta Neuropathol Commun"},{"key":"1638_CR18","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/2051-5960-2-32","volume":"2","author":"A Kobayashi","year":"2014","unstructured":"Kobayashi A, Matsuura Y, Mohri S, Kitamoto T (2014) Distinct origins of dura mater graft-associated Creutzfeldt-Jakob disease: past and future problems. Acta Neuropathol Commun 2:32","journal-title":"Acta Neuropathol Commun"},{"key":"1638_CR19","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1128\/JVI.03183-14","volume":"98","author":"A Kobayashi","year":"2015","unstructured":"Kobayashi A, Parchi P, Yamada M, Brown P, Saverioni D, Matsuura Y et al (2015) Transmission properties of atypical Creutzfeldt-Jakob disease: a clue to disease etiology. J Virol 98:3939\u20133946","journal-title":"J Virol"},{"key":"1638_CR20","doi-asserted-by":"publisher","unstructured":"Kobayashi A, Parchi P, Yamada M, Mohri S, Kitamoto T (2015) Neuropathological and biochemical criteria to identify acquired Creutzfeldt-Jakob disease among presumed sporadic cases. Neuropathol. doi: 10.1111\/neup.12270 (Epub ahead of print)","DOI":"10.1111\/neup.12270"},{"key":"1638_CR21","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1750-3639.2012.00572.x","volume":"22","author":"F Moda","year":"2012","unstructured":"Moda F, Suardis S, Di Fede G, Indaco A, Limido L, Vimercati C et al (2012) MM2-thalamic Creutzfeldt-Jakob disease: neuropathological, biochemical and transmission studies identify a distinctive prion strain. Brain Pathol 22:662\u2013669","journal-title":"Brain Pathol"},{"issue":"2","key":"1638_CR22","doi-asserted-by":"publisher","first-page":"e1005416","DOI":"10.1371\/journal.ppat.1005416","volume":"12","author":"RA Moore","year":"2016","unstructured":"Moore RA, Head MW, Ironside JW, Ritchie DL, Zanusso G, Choi YP et al (2016) The distribution of prion protein allotypes differs between sporadic and iatrogenic Creutzfeldt-Jakob disease patients. PLoS Pathog 12(2):e1005416. doi: 10.1371\/journal.ppat.1005416 (eCollection 2016 Feb)","journal-title":"PLoS Pathog"},{"key":"1638_CR23","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00401-009-0585-1","volume":"118","author":"P Parchi","year":"2009","unstructured":"Parchi P, Strammiello R, Notari S, Giese A, Langeveld JP, Ladogana A et al (2009) Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification. Acta Neuropathol 118:659\u2013671","journal-title":"Acta Neuropathol"},{"key":"1638_CR24","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1093\/brain\/awq234","volume":"133","author":"P Parchi","year":"2010","unstructured":"Parchi P, Cescatti M, Notari S, Schulz-Schaeffer WJ, Capellari S, Giese A et al (2010) Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease. Brain 133:3030\u20133042","journal-title":"Brain"},{"key":"1638_CR25","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00401-012-1002-8","volume":"124","author":"P Parchi","year":"2012","unstructured":"Parchi P, de Boni L, Saverioni D, Cohen ML, Ferrer I, Gambetti P et al (2012) Consensus classification of human prion disease histotypes allow reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA. Acta Neuropathol 124:517\u2013529","journal-title":"Acta Neuropathol"},{"key":"1638_CR26","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1099\/vir.0.033365-0","volume":"93","author":"A Peden","year":"2012","unstructured":"Peden A, McGuire LI, Appleford NE, Mallinson NE, Wilham JM, Orru CD et al (2012) Sensitive and specific detection of sporadic Creutzfeldt-Jakob disease brain prion protein using real-time quaking-induced conversion. J Gen Virol 93:438\u2013449","journal-title":"J Gen Virol"},{"key":"1638_CR27","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s40478-014-0152-4","volume":"2","author":"AH Peden","year":"2014","unstructured":"Peden AH, Sarode DP, Mulholland CR, Barria MA, Ritchie DL, Ironside JW et al (2014) The prion protein protease sensitivity, stability and seeding activity in variably protease sensitive prionopathy brain tissue suggests molecular overlaps with sporadic Creutzfeldt-Jakob disease. Acta Neuropathol Commun 2:152","journal-title":"Acta Neuropathol Commun"},{"key":"1638_CR28","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0140-6736(85)90292-2","volume":"2","author":"J Powell-Jackson","year":"1985","unstructured":"Powell-Jackson J, Weller RO, Kennedy P, Preece MA, Whitcombe EM, Newsom-Davis J (1985) Creutzfeldt-Jakob disease after administration of human growth hormone. Lancet 2:244\u2013246","journal-title":"Lancet"},{"key":"1638_CR29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF00687261","volume":"72","author":"SB Prusiner","year":"1987","unstructured":"Prusiner SB, Gabizon R, McKinley MP (1987) On the biology of prions. Acta Neuropathol 72:299\u2013314","journal-title":"Acta Neuropathol"},{"key":"1638_CR30","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1126\/science.6801762","volume":"216","author":"SB Prusiner","year":"1982","unstructured":"Prusiner SB (1982) Novel proteinaceous particles cause scrapie. Science 216:136\u2013144","journal-title":"Science"},{"key":"1638_CR31","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1093\/brain\/awv235","volume":"138","author":"P Rudge","year":"2015","unstructured":"Rudge P, Jaunmuktane Z, Adlard P, Bjurstrom N, Caine D, Lowe J et al (2015) Iatrogenic CJD due to pituitary-derived hormone with genetically determined incubation times of up to 40 years. Brain 138:3386\u20133399","journal-title":"Brain"},{"key":"1638_CR32","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/2051-5960-1-44","volume":"1","author":"S Shi","year":"2013","unstructured":"Shi S, Mitteregger-Kretzschmar G, Giese A, Kretzschmar HA (2013) Establishing quantitative real-time quaking-induced conversion (qRT-QuIC) for highly sensitive detection and quantification of PrPSc in prion-infected tissues. Acta Neuropathol Commun 1:44","journal-title":"Acta Neuropathol Commun"},{"key":"1638_CR33","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1212\/01.WNL.0000084000.27403.15","volume":"61","author":"AJ Swerdlow","year":"2003","unstructured":"Swerdlow AJ, Higgins CD, Adlard P, Jones ME, Preece MA (2003) Creutzfeldt-Jakob disease in United Kingdom patients treated with human pituitary growth hormone. Neurology 61:783\u2013791","journal-title":"Neurology"},{"key":"1638_CR34","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/labinvest.2016.27","volume":"96","author":"A Takeuchi","year":"2016","unstructured":"Takeuchi A, Kobayashi A, Parchi P, Yamada M, Morita M, Uno S et al (2016) Distinctive properties of plaque-type dura mater graft-associated Creutzfeldt-Jakob disease in cell-protein misfolding cyclic amplification. Lab Invest 96:581\u2013587","journal-title":"Lab Invest"},{"key":"1638_CR35","unstructured":"The European Creutzfeldt-Jakob Disease Surveillance Network. Diagnostic criteria. http:\/\/www.cjd.ed.ac.uk\/documents\/criteria.pdf . Accessed 06 Sept 2016"},{"key":"1638_CR36","doi-asserted-by":"crossref","unstructured":"Xiao X, Yuan J, Qing L, Cali I, Mikol J, Delisle MB, et al (2014) Comparative study of prions in iatrogenic and sporadic Creutzfeldt-Jakob disease. J Clin Cell Immunol 5:pii240","DOI":"10.4172\/2155-9899.1000240"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-016-1638-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-016-1638-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-016-1638-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T22:44:10Z","timestamp":1498344250000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-016-1638-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,3]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["1638"],"URL":"https:\/\/doi.org\/10.1007\/s00401-016-1638-x","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,3]]}}}